Source: International Congress 2015 – Emerging strategies for airway disease treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yongyao Cui (Shanghai, China), Haozhong Lu, Jianrong Xu, Zhihua Yu, Juan Li, Yu Qiu, Wenhui Zhang, Yongyao Cui. LATE-BREAKING ABSTRACT: miR-877 and its target protein HDAC6 are involved in airway inflammation. Eur Respir J 2015; 46: Suppl. 59, 4360

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Defect of HDAC7 causes impaired VEGF expression in response to hypoxia in COPD Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects Source: International Congress 2016 – Mechanisms of disease Year: 2016 TSPO a new anti-inflammatory target in the airway of COPD Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 LATE-BREAKING ABSTRACT: The involvement of serotonin in cigarette smoke-induced airway remodeling in mice Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS) Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013